Norge -
norsk -
Statens legemiddelverk
rimactazid 150 mg / 75 mg
sandoz - københavn - rifampicin / isoniazid - tablett, filmdrasjert - 150 mg / 75 mg
Norge -
norsk -
Statens legemiddelverk
rimstar
sandoz - københavn - rifampicin / isoniazid / pyrazinamid / etambutolhydroklorid - tablett, filmdrasjert - 150 mg / 75 mg / 400 mg / 275 mg
Den europeiske union -
norsk -
EMA (European Medicines Agency)
namuscla
lupin europe gmbh - mexiletine hydrochloride - myotonic lidelser - hjertetapi - namuscla er indikert for symptomatisk behandling av myotonia hos voksne pasienter med ikke-dystrophic myotonic lidelser.
Norge -
norsk -
Statens legemiddelverk
escitalopram sanoswiss 10 mg
sanoswiss uab - escitalopramoksalat - tablett, filmdrasjert - 10 mg
Norge -
norsk -
Statens legemiddelverk
escitalopram sanoswiss 5 mg
sanoswiss uab - escitalopramoksalat - tablett, filmdrasjert - 5 mg
Den europeiske union -
norsk -
EMA (European Medicines Agency)
veltassa
vifor fresenius medical care renal pharma france - patriomer sorbitex kalsium - hyperkalemi - legemidler for behandling av hyperkalemi og hyperphosphatemia - veltassa er indisert for behandling av hyperkalemi hos voksne.
Den europeiske union -
norsk -
EMA (European Medicines Agency)
xtandi
astellas pharma europe b.v. - enzalutamide - prostata neoplasmer - endokrin terapi - xtandi is indicated for:the treatment of adult men with metastatic hormone-sensitive prostate cancer (mhspc) in combination with androgen deprivation therapy (see section 5. the treatment of adult men with high-risk non-metastatic castration-resistant prostate cancer (crpc) (see section 5. the treatment of adult men with metastatic crpc who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. the treatment of adult men with metastatic crpc whose disease has progressed on or after docetaxel therapy.
Norge -
norsk -
Statens legemiddelverk
fontex 20 mg
eli lilly norge as - fluoksetinhydroklorid - dispergerbar tablett - 20 mg
Norge -
norsk -
Statens legemiddelverk
ketesse 25 mg
menarini international o.l. s.a. - deksketoprofentrometamol - tablett, filmdrasjert - 25 mg